Trial Details

TERMINATED
Basic Information
Clinical ID c1835
Identifier NCT04362254
Trial Title A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn Disease
Interventions DRUG: Spesolimab
Participant Information
Sponsor Boehringer Ingelheim
City Vienna
Country/Region Austria
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2020-05-15
Primary Completion Date 2022-05-14
Completion Date 2022-09-23